Uterine leiomyoma (fibroids) are the most common gynecologic neoplasm in women of reproductive age. As the number one cause of hysterectomy, they have a profound negative impact on women's health. Uterine leiomyoma are hormonally dependent and as such are a potential target for endocrine active compounds in the environment.
Conference: Advances in Uterine Leiomyoma Research: 2nd NIH International Congress (February 2005)
Presentation Slides
Poster Presentations
Conference Website
Final Conference Brochure
Conference Summary
Videocasts:
February 2005
Title: Advances in Uterine Leiomyoma Research (Day 1)
Length (Hours:Minutes): 05:50
February 2005
Title: Advances in Utirine Leiomyoma Research (Day 2)
Length (Hours:Minutes): 07:25
General Information
Latest Journal Publications on Uterine Fibroids
Health Topic: Uterine Fibroid (NIH)
Healthfinder.gov
Medline Plus
Uterine Fibroids (DHHS)
Ongoing studies
Ongoing Clinical Trials on Uterine Fibroids
Fibroids Growth Study (NIEHS/NCMHD)
Publications
Uterine Fibroids (FDA)
Status of Research on Uterine Fibroids (leiomyomata uteri) at the NIH
Year: March, 2006
Women's Health and the Environment (NIEHS)
Uterine Fibroids (NICHD)
Hysterectomy Surveillance- United States, 1994-1999 (CDC)
Uterine Fibroids, Management: Evidence Report (AHRQ)
Menopausal Hormone Therapy
Uterine Fibroids
Vulvodynia
Links for Researchers
Consumer Links